Carroll Financial Associates’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Carroll Financial Associates’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Hold	2,000	–	–	﹤0.01%	1595
2021 Q3	$1K	Hold	2,000	–	–	﹤0.01%	1752
2021 Q2	$3K	Hold	2,000	–	–	﹤0.01%	1547
2021 Q1	$4K	Hold	2,000	–	–	﹤0.01%	1431
2020 Q4	$2K	Hold	2,000	–	–	﹤0.01%	1425
2020 Q3	$2K	Hold	2,000	–	–	﹤0.01%	1381
2020 Q2	$2K	Hold	2,000	–	–	﹤0.01%	1386
2020 Q1	$1K	Hold	2,000	–	–	﹤0.01%	1419
2019 Q4	$2K	Hold	2,000	–	–	﹤0.01%	1407
2019 Q3	$2K	Hold	2,000	–	–	﹤0.01%	1373
2019 Q2	$3K	Hold	2,000	–	–	﹤0.01%	1345
2019 Q1	$3K	Hold	2,000	–	–	﹤0.01%	1227
2018 Q4	$3K	Hold	2,000	–	–	﹤0.01%	1156
2018 Q3	$3K	Hold	2,000	–	–	﹤0.01%	1175
2018 Q2	$3K	Hold	2,000	–	–	﹤0.01%	1152
2018 Q1	$4K	Buy	+2,000	New	+$2.68K	﹤0.01%	1089

Other funds holding MBII

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carroll Financial Associates's MBII Position: Q4 2021 in Review

Carroll Financial Associates held its Marrone Bio Innovations, Inc. (MBII) position steady in Q4 2021 at 2,000 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

Carroll Financial Associates first reported a position in MBII in Q1 2018 and has held it in 16 quarters since. The position peaked at $4K in Q1 2021. 74 funds tracked by Wall St. Rank hold MBII as of Q4 2021.

Carroll Financial Associates held 2,000 shares of Marrone Bio Innovations, Inc. worth $1K as of Q4 2021.
Carroll Financial Associates left its Marrone Bio Innovations, Inc. share count unchanged in Q4 2021.
Marrone Bio Innovations, Inc. made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1595 holding.
Carroll Financial Associates first reported a position in Marrone Bio Innovations, Inc. in Q1 2018 and has held it in 16 quarters since.
Carroll Financial Associates's Marrone Bio Innovations, Inc. position peaked at $4K in Q1 2021.
74 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.